genome.
Abelson murine leukemia virus (A-MuLV) is a defective retrovirus that causes a rapidly progressive lymphosarcoma in mice and will induce growth of transformed lymphoid cells after in vitro infection of mouse bone marrow cells (21) . At least some A-MuLV-induced lymphoid cell lines appear to be related to cells of the Blymphocyte lineage because they contain immunoglobulin-related polypeptides (18, 19, 27, 28, 29, 33) .
All A-MuLV-transformed cell lines, producer or nonproducer, contain a protein of molecular weight 120,000 that is made under the direction of the A-MuLV genome (20, 35) . This is the only A-MuLV-specific protein that has been identified. Like the murine sarcoma viruses, A-MuLV needs a helper virus to provide its virion structural proteins.
A-MuLV is also capable of transforming fibroblastic cell lines in vitro (25) (22) . Even lymphoid cells producing highly oncogenic helper viruses have been found to cease virus production after being carried in culture for several months (35) .
Although the question has not been directly investigated previously, our experience with fibroblastic cells that are infected with A-MuLV has been that stable producers and nonproducers result. The instability of helper virus production seen with lymphoid cells has not been evident. Furthermore, when fibroblastic cells are infected with Moloney murine leukemia virus (M-MuLV), a representative effective helper virus, stable producers, and defective producers result (26) . The defective producers appear to arise from infection with a variety of mutant proviruses giving rise to a variety of stable phenotypes.
The disparity between the apparently stable fibroblast-M-MuLV relationship and the apparently unstable relationship between A-MuLVtransformed lymphoid cells and helper viruses led us to undertake a systematic investigation of virus production by A-MuLV-transformed cells. We report here that most A-MuLV-transformed lymphoid cells evolve to a state where no helper virus production is evident but where the cells make a highly defective particle that probably arises from an endogenous provirus in the original target cell.
MATERIALS AND METHODS Cells. NIH/3T3, BALB/3T3, SC-1, XC, and FG-10 cells were grown in Dulbecco modified Eagle medium supplemented with 10% calf serum (Microbiological Associates). Transformed lymphoid cell lines were derived from individual foci of A-MuLV-infected bone marrow cells and adapted to growth in RPMI-1640 medium supplemented with 10% heat-inactivated fetal calf serum and 50 uM 2-mercaptoethanol (Kodak Chemical Co.) (22) . SWR4 was derived from an SWR/ J mouse; 242, TB-li, and TB8-5 were derived from NIH/Swiss mice; 18-4 was from a BALB/cJ mouse; and BR48 was from a C57BR/cdJ mouse. Superinfected cell lines are designated /M-MuLV.
The series of transformed fibroblasts was derived by infecting NIH/3T3 cells at an approximate multiplicity of infection (MOI) of 0.025 focus-forming unit (FFU) and 0.05 plaque-forming unit (PFU) per cell. After a 1.5-h adsorption period, the cells were washed and trypsinized, mixed with agar-containing medium, and plated in a final concentration of 0.3% agar at 103 to 104 cells per 10-cm plate. After 17 days at 38°C, transformed colonies were visible by eye and were picked by using a Pasteur pipette. They were transferred to 60-mm dishes and grown up and tested for release of reverse transcriptase activity and virus by XC and focus assays.
Viruses. A-MuLV stocks were routinely prepared from an NIH/3T3-derived, A-MuLV-transformed cell line, ANN-1 (25) , rescued with M-MuLV-1 (6 4°C . Fractions of 0.5 ml were collected and assayed as described above.
The analysis of virion RNA was done on labeled virions produced and purified as described above. The virus from the gradient was lysed in 2% sodium dodecyl sulfate (SDS), and the RNA was purified by phenolchloroform extraction and ethanol precipitation. RNA was analyzed by sucrose gradient centrifugation by the method of Kerr et al. (10) .
Protein analysis. Virions were purified by sucrose gradient as described above and suspended in 20 mM J. VIROL.
Tris (pH 8.3). They were lysed by the addition of NP-40 (final concentration, 1%) and heated at 67°C for 5 min. Iodination was performed by using lactoperoxidase (17) or chloramine T (8) . Immunoprecipitation was performed by using sera shown to be specific for M-MuLV p30 and gp7O (16) by techniques described in detail elsewhere (34) . Briefly, labeled virus was precleared with normal serum and Staphlycoccus aureus Cowan strain 1 (11) . Immunoprecipitates were then made by incubating the supernatants with 5 p1 of serum and then collecting antigen-antibody complexes with S. aureus. SDS-polyacrylamide gel electrophoresis was performed on the discontinuous stacking system of Laemmli (12) 18-4. Cocultivation studies with the defective producers, 242 and SWR4, were carried out to determine if any infectious virus could be detected ( (21) and those designated /M-MuLV had been superinfected with the indicated virus.
b Reverse transcriptase assays were performed by using an oligo(dT) primer and poly(rA) template as described in Materials and Methods. Values of less than 500 cpm were considered to be background. e Plaque-forming units of M-MuLV were determined by the XC plaque assay (23) . Focus-forming units of AMuLV were determined by the fibroblast transformation assay of Scher and Siegler (25) .
d The efficiency of virus stocks to transform bone marrow cells was determined by using NIH/Swiss bone marrow (21) .
'In vivo inoculations were done intraperitoneally in neonatal NIH/Swiss mice using filtered reverse transcriptase-positive supernatants. All mice were observed for 5 to 6 months. f ND, Not determined. was recovered from SWR4 even after treatment with iododeoxyuridine (3) and cocultivation with indicator cells (data not shown), but infectious ecotropic virus produced by SWR4 superinfected with M-MuLV (SWR4/M-MuLV) was readily detectable ( Table 2) .
The proportion of cell lines with the defective producer phenotype was very high when randomly isolated cell lines were obtained from various mouse strains including NIH/Swiss, SWR/J, BALB/cAN, C57L/J, and C57BL/6J. To systematically determine the frequency of defective producers, several series of lymphoid clones from individual experiments were isolated and monitored for reverse transcriptase and infectious virus production after various times (Table 3) . In experiments 1 and 2, clones were adapted to liquid medium, a procedure that takes 3 to 6 weeks once the foci are removed from agarose. Most clones in these experiments were defective producers. In experiment 3, cell lines were tested during their adaptation to continuous culture. One to two weeks after removing the cells from agarose, 57% of the focal isolates produced large amounts of virus (>103 PFU per 106 cells). After 1 month in liquid medium, the majority of cultures still released virus, but the amount of virus produced by the cells had decreased and some cell lines now displayed the defective phenotype. After 2 months in vitro (data not shown), three cultures classified at 1 month as low producers were retested and had become defective producers. One cell line classified at 1 month as a high producer was retested at 2 months and was stable, as were two cell lines designated as defective producers.
The interaction of M-MuLV with A-MuLVtransformed lymphoid cells differs from its interaction with fibroblasts in two ways. First, the interaction of M-MuLV with fibroblasts is a stable one. As mentioned previously, subclones of M-MuLV-infected fibroblasts are all virus producers (26) . In a variety of situations we have examined previously cloned, infected fibroblasts for loss of virus production and have not observed such loss. Second, transformation of fibroblasts with A-MuLV and M-MuLV helper generated a different pattern of phenotypes from that seen in lymphoid transformants (Table 4) . Mainly producer or nonproducer cells were formed and the one defective producer in Table  4 may represent a spontaneous mutation because such mutant M-MuLV is often produced (26) . Characterization of the defective virions. One defective producer line was chosen for intensive study because it produced more defective particles than the others. This line, SWR4, released sedimentable particles containing reverse transcriptase (Table 1) . To determine if the particles were virion-like, SWR4 cells were labeled with [3H]uridine and the labeled, re- 
b Before analysis by reverse transcriptase assay (22) supernatants were concentrated 10-fold by centrifugation. Backgrounds were not subtracted; values of less than 500 cpm were not significantly above background.
leased particles were sedirnented to equilibrium in a 25 to 45% sucrose gradient (Fig. 1) . M-MuLV labeled with 32p was used as an internal standard, and the particles from the superinfected producer lymphoid line, SWR4/M-MuLV, were analyzed in parallel. The defective producer released 3H-labeled particles containing reverse transcriptase activity that were of the same density as M-MuLV and the infectious virions of SWR4/M-MuLV.
To study their morphology, SWR4 and 18-4 particles were isolated, negatively stained, and examined by electron microscopy (Fig. 2) . Although both preparations contained type C particles, the 18-4 particles had readily evident spikes characteristic of glycoprotein, but the SWR4 particles lacked such spikes.
To examine the RNA content of these particles, [3H]uridine-labeled RNA was extracted from the purified particles and displayed on a 15 to 30% sucrose gradient (Fig. 3) . The producer, 18-4, released particles having RNA that sedimented at 70S as well as low-molecular-weight RNA, presumably mainly tRNA, that remained near the top of the gradient. The particles from SWR4 cells contained no demonstrable largemolecular-weight RNA, although it did contain some low-molecular-weight RNA.
As an alternative method of studying the RNA of the particles, we compared exogenous reverse transcriptase activity to endogenous activity in defective and nondefective particles. In the exogenous assay, oligodeoxythymidylate primer and polyriboadenylate template were added to the reaction mix to quantitate enzymatic activity. The endogenous assay relied on the virions to supply 70S genomic RNA and tRNA, the natural template and primer. The ratio of endogenous to exogenous activity should be a measure of the relative content of genomic RNA. SWR4 particles contained only 4 to 10% of the endogenous activity in particles from the normal producer, (Table 5 ). This result confirms the lack of high-molecular-weight RNA (Fig. 4) .
The major structural protein of standard and defective virions was analyzed by labeling deter- (Table 1) , however, argues that there is little ecotropic glycoprotein present on the surface of the defective producer cells. The lack of glycoprotein in the defective virus is consistent with the absence of spikes when particles were examined by electron microscopy.
One possible origin of p28 could be processing of the M-MuLV gag polyprotein to generate p28 rather than p30. To determine if the defective producers were intrinsically able to synthesize p30 from the M-MuLV gag polyprotein, the virion proteins from SWR4/M-MuLV were analyzed. A mixture of p28 and p30 was discernable (Fig. 5, lane A2) , implying that the defective producers can process the M-MuLV polyprotein normally.
Origin of defective particles. The genetic information coding for the defective virions might originate in the Abelson genome, in an altered helper virus, or in an endogenous virus. The Abelson virus genome is an unlikely source of the information for the defective virions because it codes for a protein, P120, that lacks most of the antigenicity of p30, does not give rise to detectable p30-like cleavage products, and lacks determinants of reverse transcriptase (35, 20 Possible sources for the p28 were M-MuLV and the only known SWR/J endogenous virus (32) . To compare the defective virion p28 with the major structural proteins of these viruses, virions were purified from SWR4 cells, 18-4 cells, and from SC-1 cells infected with the SWR/J virus. After disruption of the virions, the proteins were iodinated, immunoprecipitated with a serum specific for p30, and displayed by electrophoresis through an SDS-polyacrylamide gel.
The bands containing the major structural protein were identified by autoradiography and excised from the dried gel. After rehydration, the gels slices were placed on a new gel and mixed with unlabeled M-MuLV p30, and the proteins were compared by partial proteolytic cleavage by the method of Cleveland et al. (4) . Coomassie blue staining of the gel provided an internal standard with which to compare the autoradiogram and demonstrated that equal digestion occurred in all samples (Fig. 6) . The major structural protein of the endogenous SWR/J virus migrated with an apparent molecular weight of 27,000 (this difference in migration is evident in Fig. 6 tein of molecular weight 30,000, the cleavage 2 3 2 3 pattern of its p30 is different from that of our standard M-MuLV. Therefore, a stock of Abelson virus was produced with M-MuLV-TB helper, and this was used to derive a series of W^> * lymphoid clones from an NIH/Swiss mouse. Again a number of nornal and defective producers was isolated and the defective virions of * * the tested cell line were shown to contain p28. W When the proteins were compared by digestion with S. aureus protease (Fig. 7) , a characteristic peptide difference was visible between the p30 of the lymphoid producer releasing standard MMuLV ( differences between them, especially one band present in the SWR/J virus cleaved with S. aureus protease that was absent in the digests of the other two (arrow, Fig. 6 ; the lack of this peptide in the SWR4 p28 is more evident in the data presented in Fig. 7) . Furthermore, many of the cleavage products of p28 migrated somewhat faster than those of M-MuLV p30, presumably reflecting the smaller size of the original protein.
The similarity of the digestion products from M-MuLV p30 and the defective particle p28 and the similar sedimentation of reverse transcriptase from the two virion preparations suggested that a possible origin of the defective virions could be through an alteration of the helper virus. When M-MuLV virus infects fibroblasts it mutates at a rapid rate but produces a variety of defects, none of which include a smaller p30 (26) . By contrast, the particles produced by the defective lymphoid producers are homogeneous in phenotype to the extent that all contain reverse transcriptase and lack infectivity in the XC and focus assays, and three have p28. The lymphoid cells could, however, either cause or select for a particular defect within the helper virus. This was tested by using as a helper another strain of M-MuLV (M-MuLV-TB) that can be distinguished from our standard M-MuLV and studying the resulting defective virions for changes in changed and similar to that of M-MuLV (lanes 3), however, suggesting that p28 is not derived from the helper virus. It is also evident from the lOx digests (Fig. 7) producers. In the series of transformed fibroblasts described here, only one clone released reverse transcriptase-containing particles that were not infectious in the XC and focus assays. It is probable that this clone is the result of a spontaneous mutation of M-MuLV, an event that occurs frequently in the helper virus (26) . Because the level of reverse transcriptase is quite low in the lymphoid defective producers, it is possible that nonproducer fibroblasts may also release these particles but at a level not detectable in our assay.
The lymphoid defective producers may all have initially contained a competent helper virus genome because analysis of lymphoid clones before they were fully adapted to liquid medium showed that many produce infectious virus, although often at low titers. Furthermore, the inability of some helper viruses to make AMuLV competent to transform lymphoid cellsa behavior that does not correlate with helper virus tropism-suggests that the helper may play an active role in the early intracellular stages of A-MuLV lymphoid cell transformation (22, 24) . Which helper virus function is needed and why oncogenicity of the helper correlates with lymphoid cell transformation but not fibroblast transformation are unanswered questions.
As lymphoid transformants grow, many cease to release infectious virus but continue to release defective virions. We have previously shown that A-MuLV-transformed lymphoid cells infected with helper virus may cease virus production as they are passaged (22, 35) . This does not appear to be solely due to selection, because repeatedly cloned cell lines have been found to cease virus production. Lymphoid cells appear able to regulate helper virus gene expression because when A-MuLV nonproducer lymphoid cells are superinfected with a helper of low oncogenicity, they cease releasing virus after a few days. Even some A-MuLV-transformed lymphoid cells producing a helper virus of high oncogenicity have been found to cease virus production when carried in culture for several months. Cell lines derived from tumors induced by the in vivo inoculation of Friend MuLV complex into certain mouse strains also ceased to release infectious virus as the cells were passaged in vitro (7) . By contrast, fibroblasts seem to stably release virus once a productive infection is established even with a helper of low oncogenicity.
The defective particles released by the lymphoid cells were found to have the density of normal virions and to contain reverse transcriptase of normal size. However, no 70S RNA was found as determined by analysis of [3H]uridine-labeled virions and by the endogenous reverse transcriptase assay. The low level of activity noted in the endogenous assays probably reflects transcription of small RNA packaged in the virions. It has been previously shown that virions lacking 70S RNA are produced after treatment of cells with actinomycin D, and they also contain lowmolecular-weight RNA (13, 15) . It is possible, though, that these analyses could be misleading if there were a relative overabundance of reverse transcriptase activity in the virions.
The defective virion's major structural protein migrates with an apparent molecular weight of 28,000. The superinfectability of the defective producers suggests that the cells lack ecotropic glycoprotein and the virions are without spikes when viewed with the electron microscope; virions lacking glycoprotein have been demonstrated previously (5) . We cannot be entirely certain, however, that the particles lack glycoprotein because a glycoprotein that does not react with antiserum made against M-MuLV gp70 could be present.
The defective virions could either originate from the A-MuLV genome, represent alteration of the helper virus, or derive from an endogenous virus or some combination of these. The only known product of the A-MuLV genome is a 120,000-molecular-weight protein (P120). Because an antiserum has been produced that fails to precipitate A-MuLV P120 but reacts with both M-MuLV p30 and the defective virion p28 (unpublished data), the A-MuLV genome is an unlikely source for p28. Furthermore, because the Abelson genome codes for only a small portion of the major structural protein and lacks coding capacity for the reverse transcriptase, it is unlikely to code for any of the known components of the defective virions. An alteration of the helper virus is unlikely because defective virions in lymphoid cells induced with another strain of M-MuLV as helper (M-MuLV-TB), contained p28 with an unaltered cleavage pattern and one that was different from that of the p30 of M-MuLV-TB. A modification of the helper virus could have occurred, however, that changed p30 to p28 and obliterated the helper's characteristic peptide.
The defective virus could in principle derive from a defective virus carried in our viral stocks. Although the generation of defective producers has been observed with several different wellcloned stocks of virus, we cannot rigorously exclude this explanation. We feel that the most likely origin of the defective genome, however, is from an endogenous mouse virus. When we tested the only known endogenous virus of the SWR/J mouse we found that its major structural protein had a size different from that of p28. Although the cleavage patterns of the endogenous virus p27 and defective virion p28 were similar, there were minor differences. Analysis of the DNA from many strains of laboratory mice, however, has demonstrated the existence of multiple genes with homology to M-MuLV (31) . The existence of another undetected endogenous virus is quite possible because it appears to be without infectivity and might only express itself in early lymphoid cells. In this regard it is important to remember that endogenous viral genes are known to be expressed in various tissues including B-lymphoid cells (1, 14, 30 
